Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Circulating Biomarker market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Circulating Biomarkermarket, defines the market attractiveness level of Circulating Biomarker market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Circulating Biomarker industry, describes the types of Circulating Biomarker market, the applications of major players and the market size, and deeply analyzes the current situation of the global Circulating Biomarker market and the development prospects and opportunities of Circulating Biomarker industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Circulating Biomarker market in Chapter 13.
By Player:
Fraunhofer-Gesellschaft (Germany)
Bio-Rad Laboratories (US)
Myriad Genetics (US)
Janssen Diagnostics (US)
Biocept Inc (US)
MDxHealth SA (US)
QIAGEN (Netherlands)
Guardant Health (US)
Trovagene (US)
Roche (Switzerland)
By Type:
Lung
Breast
Colorectal
Prostate
By End-User:
Reference Laboratory
Research Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Circulating Biomarker Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Circulating Biomarker Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Circulating Biomarker Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Circulating Biomarker Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Circulating Biomarker Market Analysis and Outlook to 2022
-
7.1 Global Circulating Biomarker Consumption (2017-2022)
-
7.2 United States Circulating Biomarker Consumption (2017-2022)
-
7.3 Europe Circulating Biomarker Consumption (2017-2022)
-
7.4 China Circulating Biomarker Consumption (2017-2022)
-
7.5 Japan Circulating Biomarker Consumption (2017-2022)
-
7.6 India Circulating Biomarker Consumption (2017-2022)
-
7.7 South Korea Circulating Biomarker Consumption (2017-2022)
8 Region and Country-wise Circulating Biomarker Market Analysis and Outlook to 2028
-
8.1 Global Circulating Biomarker Consumption Forecast (2022-2028)
-
8.2 United States Circulating Biomarker Consumption Forecast (2022-2028)
-
8.3 Europe Circulating Biomarker Consumption Forecast (2022-2028)
-
8.4 China Circulating Biomarker Consumption Forecast (2022-2028)
-
8.5 Japan Circulating Biomarker Consumption Forecast (2022-2028)
-
8.6 India Circulating Biomarker Consumption Forecast (2022-2028)
-
8.7 South Korea Circulating Biomarker Consumption Forecast (2022-2028)
9 Global Circulating Biomarker Market Outlook by Types and Applications to 2022
-
9.1 Global Circulating Biomarker Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Lung Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Breast Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Colorectal Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Prostate Consumption and Growth Rate (2017-2022)
-
9.2 Global Circulating Biomarker Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Reference Laboratory Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Centers Consumption and Growth Rate (2017-2022)
10 Global Circulating Biomarker Market Outlook by Types and Applications to 2028
-
10.1 Global Circulating Biomarker Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Lung Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Breast Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Colorectal Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Prostate Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Circulating Biomarker Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Reference Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Circulating Biomarker Import and Export Analysis (Top 5 Countries)
-
11.1 Global Circulating Biomarker Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Circulating Biomarker Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Circulating Biomarker Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Circulating Biomarker Market Competitive Analysis
-
14.1 Fraunhofer-Gesellschaft (Germany)
-
14.1.1 Fraunhofer-Gesellschaft (Germany) Company Details
-
14.1.2 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Product and Service
-
14.2 Bio-Rad Laboratories (US)
-
14.2.1 Bio-Rad Laboratories (US) Company Details
-
14.2.2 Bio-Rad Laboratories (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bio-Rad Laboratories (US) Circulating Biomarker Product and Service
-
14.3 Myriad Genetics (US)
-
14.3.1 Myriad Genetics (US) Company Details
-
14.3.2 Myriad Genetics (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Myriad Genetics (US) Circulating Biomarker Product and Service
-
14.4 Janssen Diagnostics (US)
-
14.4.1 Janssen Diagnostics (US) Company Details
-
14.4.2 Janssen Diagnostics (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Diagnostics (US) Circulating Biomarker Product and Service
-
14.5 Biocept Inc (US)
-
14.5.1 Biocept Inc (US) Company Details
-
14.5.2 Biocept Inc (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biocept Inc (US) Circulating Biomarker Product and Service
-
14.6 MDxHealth SA (US)
-
14.6.1 MDxHealth SA (US) Company Details
-
14.6.2 MDxHealth SA (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 MDxHealth SA (US) Circulating Biomarker Product and Service
-
14.7 QIAGEN (Netherlands)
-
14.7.1 QIAGEN (Netherlands) Company Details
-
14.7.2 QIAGEN (Netherlands) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 QIAGEN (Netherlands) Circulating Biomarker Product and Service
-
14.8 Guardant Health (US)
-
14.8.1 Guardant Health (US) Company Details
-
14.8.2 Guardant Health (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Guardant Health (US) Circulating Biomarker Product and Service
-
14.9 Trovagene (US)
-
14.9.1 Trovagene (US) Company Details
-
14.9.2 Trovagene (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Trovagene (US) Circulating Biomarker Product and Service
-
14.10 Roche (Switzerland)
-
14.10.1 Roche (Switzerland) Company Details
-
14.10.2 Roche (Switzerland) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Roche (Switzerland) Circulating Biomarker Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Circulating Biomarker
-
Figure Circulating Biomarker Picture
-
Table Global Circulating Biomarker Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Circulating Biomarker Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Circulating Biomarker Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Circulating Biomarker Consumption by Country (2017-2022)
-
Figure United States Circulating Biomarker Consumption and Growth Rate (2017-2022)
-
Table Europe Circulating Biomarker Consumption and Growth Rate (2017-2022)
-
Figure China Circulating Biomarker Consumption and Growth Rate (2017-2022)
-
Figure Japan Circulating Biomarker Consumption and Growth Rate (2017-2022)
-
Figure India Circulating Biomarker Consumption and Growth Rate (2017-2022)
-
Figure South Korea Circulating Biomarker Consumption and Growth Rate (2017-2022)
-
Figure Global Circulating Biomarker Consumption Forecast by Country (2022-2028)
-
Figure United States Circulating Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Circulating Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Circulating Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Circulating Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Circulating Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Circulating Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Consumption and Growth Rate (2017-2022)
-
Figure Global Reference Laboratory Consumption and Growth Rate (2017-2022)
-
Figure Global Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Reference Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Circulating Biomarker Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Circulating Biomarker Export by Region (Top 5 Countries) (2017-2028)
-
Table Fraunhofer-Gesellschaft (Germany) (Foundation Year, Company Profile and etc.)
-
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Product and Service
-
Table Bio-Rad Laboratories (US) (Foundation Year, Company Profile and etc.)
-
Table Bio-Rad Laboratories (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories (US) Circulating Biomarker Product and Service
-
Table Myriad Genetics (US) (Foundation Year, Company Profile and etc.)
-
Table Myriad Genetics (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myriad Genetics (US) Circulating Biomarker Product and Service
-
Table Janssen Diagnostics (US) (Foundation Year, Company Profile and etc.)
-
Table Janssen Diagnostics (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Diagnostics (US) Circulating Biomarker Product and Service
-
Table Biocept Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Biocept Inc (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocept Inc (US) Circulating Biomarker Product and Service
-
Table MDxHealth SA (US) (Foundation Year, Company Profile and etc.)
-
Table MDxHealth SA (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table MDxHealth SA (US) Circulating Biomarker Product and Service
-
Table QIAGEN (Netherlands) (Foundation Year, Company Profile and etc.)
-
Table QIAGEN (Netherlands) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table QIAGEN (Netherlands) Circulating Biomarker Product and Service
-
Table Guardant Health (US) (Foundation Year, Company Profile and etc.)
-
Table Guardant Health (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guardant Health (US) Circulating Biomarker Product and Service
-
Table Trovagene (US) (Foundation Year, Company Profile and etc.)
-
Table Trovagene (US) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trovagene (US) Circulating Biomarker Product and Service
-
Table Roche (Switzerland) (Foundation Year, Company Profile and etc.)
-
Table Roche (Switzerland) Circulating Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche (Switzerland) Circulating Biomarker Product and Service
-
